Muscogee (Creek) Nation offers Regeneron monoclonal antibody treatments at new health center

The treatment is highly effective in reducing hospitalizations and deaths from COVID-19 if administered early in the course of the disease

TULSA — If caught early, COVID-19 doctors can aggressively treat the disease by giving the patient an infusion of monoclonal antibodies, essentially man-made versions of the antibodies the body would produce normally if humans had immunity to the virus.

This week, the Muscogee (Creek) Nation announced it is offering the Regeneron monoclonal antibody regimen at its new facility, Council Oak Comprehensive Healthcare.

Sec. Terry tells KRMG he pointed out the infusion chairs, remarking they they didn’t know what they were going to do with them.

The facility was formerly occupied by a cancer treatment clinic, and when the Creek Nation purchased it Secretary of Health Shawn Terry was touring the building with State Secretary of Health Dr. Lance Frye.

It was Dr. Frye, he says, who came up with the idea of a monoclonal antibody infusion center.

“No one will be charged for this drug,” Terry said Wednesday.

The cost of the Regeneron, and much of the labor involved, is covered by the federal government.